{"doi":"10.1186\/1744-8603-3-4","coreId":"213329","oai":"oai:eprints.lse.ac.uk:26157","identifiers":["oai:eprints.lse.ac.uk:26157","10.1186\/1744-8603-3-4"],"title":"Balancing intellectual monopoly privileges and the need for essential medicines","authors":["Martin, Greg","Sorenson, Corinna","Faunce, Thomas"],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2007-06-12","abstract":"This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest, particularly as they pertain to the Doha Declaration. In this editorial, we consider the debate, the conclusions thereof, and identify five questions that should be considered by key stakeholders in ongoing discussions","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"BioMed Central Ltd.","rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:eprints.lse.ac.uk:26157<\/identifier><datestamp>\n      2012-06-12T09:04:54Z<\/datestamp><setSpec>\n      74797065733D43454E54524553:4C53455F52435F3839<\/setSpec><\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:relation>\n    \n      \n        http:\/\/eprints.lse.ac.uk\/26157\/<\/dc:relation><dc:title>\n        Balancing intellectual monopoly privileges and the need for essential medicines<\/dc:title><dc:creator>\n        Martin, Greg<\/dc:creator><dc:creator>\n        Sorenson, Corinna<\/dc:creator><dc:creator>\n        Faunce, Thomas<\/dc:creator><dc:subject>\n        RA Public aspects of medicine<\/dc:subject><dc:description>\n        This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest, particularly as they pertain to the Doha Declaration. In this editorial, we consider the debate, the conclusions thereof, and identify five questions that should be considered by key stakeholders in ongoing discussions.<\/dc:description><dc:publisher>\n        BioMed Central Ltd.<\/dc:publisher><dc:date>\n        2007-06-12<\/dc:date><dc:type>\n        Article<\/dc:type><dc:type>\n        PeerReviewed<\/dc:type><dc:identifier>\n          Martin, Greg and Sorenson, Corinna and Faunce, Thomas  (2007) Balancing intellectual monopoly privileges and the need for essential medicines.  Globalization and Health, 3 (4).   ISSN 1744-8603     <\/dc:identifier><dc:relation>\n        http:\/\/www.globalizationandhealth.com\/home<\/dc:relation><dc:relation>\n        10.1186\/1744-8603-3-4<\/dc:relation><\/oai_dc:dc><\/metadata><\/record>","journals":null,"language":null,"relations":["http:\/\/eprints.lse.ac.uk\/26157\/","http:\/\/www.globalizationandhealth.com\/home","10.1186\/1744-8603-3-4"],"year":2007,"topics":["RA Public aspects of medicine"],"subject":["Article","PeerReviewed"],"fullText":null}